NIH-funded research R21 grant

How Bordetella pertussis interacts with human nasal cells

Official title: Interaction of Bordetella pertussis with human nasal epithelium

Funded at Ohio State University · NIH-11093534 · Data updated 2026-11-12

This study is looking at how the whooping cough germ sticks around in the noses of people, even those who have been vaccinated and might not show many symptoms, to help find ways to make vaccines better and understand how the disease spreads.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startMay 22, 2024
Project endMarch 31, 2026
Funding year2025
Award (this year)$196,875
NIH project number5R21AI183669-02
Project IDNIH-11093534 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are infants and young children, especially those under 11 years old who may be at risk for whooping cough.

Less likely to help

Patients who are older than 11 years or those who have already been diagnosed with chronic respiratory conditions may not benefit from this research.

What this research studies

This research investigates how the bacterium Bordetella pertussis, which causes whooping cough, interacts with human nasal epithelial cells. The study aims to understand the mechanisms by which this bacterium attaches to and persists in the nasal cavity, particularly in vaccinated individuals who may show mild or no symptoms. By using human nasal epithelial cultures that mimic the natural environment of the human nose, researchers will explore how biofilm formation contributes to long-term infection. This approach could provide insights into improving vaccine effectiveness and understanding disease transmission.

Why it matters

Potential benefit: If successful, this research could lead to improved vaccines and strategies to prevent whooping cough, particularly in young children.

How similar studies have gone: Previous research has shown that understanding bacterial interactions in human tissues can lead to significant advancements in vaccine development, indicating potential success for this approach.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Deora, Rajendar K — Ohio State University
  • Study coordinator: Deora, Rajendar K

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.